Breathing test for COPD patients starting triple therapy
Part of Lungs & breathing clinical trials.
This study looks at whether a breathing test called oscillometry can help guide treatment when switching from two inhaled medicines to triple therapy (including a steroid) for people with COPD who often have flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a diagnosis of COPD (chronic obstructive pulmonary disease).
- Your COPD is moderate to severe but stable, based on lung function tests.
- You are currently using two long-acting inhaled bronchodilators (LABA/LAMA) and are ready to add an inhaled steroid, making it 'triple therapy'.
- You have had COPD flare-ups (exacerbations) before.
- A recent blood test shows a high count of a certain white blood cell (eosinophils >100 cells/mL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple breathing test called oscillometry along with machine learning to better understand lung conditions like COPD, asthma, and interstitial lung disease. It may help find new ways to diagnose and track these diseases.
This study looks at how a simple breath test (measuring nitric oxide in the air you breathe out) might help predict when COPD symptoms flare up. If you take triple inhaler therapy, this study could help you and your doctor better manage your condition and prevent future flare-ups.
This study compares simple breathing tests (oscillometry and FeNO) used by your primary care doctor against a specialist's diagnosis to see if they can accurately tell if you have asthma or COPD. If you have symptoms like wheezing, cough, or shortness of breath but haven't been diagnosed yet, this trial may help improve how these conditions are found.
This study tests a new combination inhaler (fluticasone, formoterol, and glycopyrronium) for people with COPD. It aims to see if this triple therapy can improve breathing and quality of life compared to current treatments.
This study looks at how often heart problems or stroke happen in people with COPD after they start a specific “triple therapy” inhaler. It may help doctors understand whether these inhalers change cardiovascular (heart) or cerebrovascular (stroke) risk.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.